The risk of autoimmunity associated with tumor immunotherapy

Research output: Contribution to journalComment/debate

80 Scopus citations

Abstract

In summary, tumor vaccination via the targeting of self-antigens expressed in tumor cells can be achieved without undue autoimmune pathology, largely due to an apparent difference between the requirements for inducing tumor regression and autoimmune pathology. Such treatments are, however, not without associated risks or the need for compromises and will require well thought-out choices to be made on a case-by-case basis.

Original languageEnglish (US)
Pages (from-to)789-792
Number of pages4
JournalNature Immunology
Volume2
Issue number9
DOIs
StatePublished - Dec 1 2001

    Fingerprint

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this